LSM3, NDUFB3, and PTGS2 may be potential biomarkers for BRCA1-mutation positive breast cancer
By: Kang Hu, Fengjiao Gan, Xue Wang, Lin Xu, Qiaoyuan Wu, Ni Jiang and Suhong Sun
Authors
Kang Hu
Breast and Thyroid Disease Medical Center, Hospital of Zunyi Medical University, China
Fengjiao Gan
Breast and Thyroid Disease Medical Center, Hospital of Zunyi Medical University, China
Xue Wang
Breast and Thyroid Disease Medical Center, Hospital of Zunyi Medical University, China
Lin Xu
Department of Oncology Laboratory, Affiliated Hospital of Zunyi Medical University, China
Qiaoyuan Wu
Department of Oncology Laboratory, Affiliated Hospital of Zunyi Medical University, China
Ni Jiang
Department of Oncology Laboratory, Affiliated Hospital of Zunyi Medical University, China
Suhong Sun
Breast and Thyroid Disease Medical Center, Hospital of Zunyi Medical University, China
Language: English
Page range: 381 - 391
Submitted on: Jul 23, 2020
Accepted on: Oct 28, 2020
Published on: Nov 18, 2020
Published by: Romanian Association of Laboratory Medicine
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:
© 2020 Kang Hu, Fengjiao Gan, Xue Wang, Lin Xu, Qiaoyuan Wu, Ni Jiang, Suhong Sun, published by Romanian Association of Laboratory Medicine
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.